Ray Gustin Managing Director

Ray Gustin has over 25 years of senior investment management experience managing hedge fund and private equity portfolios and investments, including 19 years at Drake Capital. In this capacity he has invested extensively in public and private market strategies across a wide range of asset classes and geographic markets. Prior to joining Drake Capital in 2003, Mr. Gustin was Managing Director and General Partner at private equity firm Cornerstone Equity Investors, where he invested in innovative early-stage companies in the technology, communications, and business services sectors. Prior to joining Cornerstone in 2000, Mr. Gustin was Managing Director of the US M&A practice of TD Securities, where he advised clients and invested the bank’s proprietary capital in numerous private equity investments. He joined TD Bank in 1989 in the bankruptcy/restructuring advisory practice, where he completed corporate restructurings in both cyclical and non-cyclical industries. Mr. Gustin is actively committed to innovation in cancer research and public health.  He is currently co-Chair of Memorial Sloan Kettering’s Patient & Family Advisory Council for Quality and has been a member of Memorial Sloan Kettering’s Institutional Review Board (IRB) since 2020. Mr. Gustin holds an M.B.A. from the University of Chicago and a B.S. with honors from Pennsylvania State University.